# Punch Biopsy as a Diagnostic Keystone for Metastatic Cardiac Angiosarcoma Treated With Anthracycline-Based Chemotherapy: A Case Report

## TL;DR

This case report describes a rare cardiac angiosarcoma diagnosed via punch biopsy and treated with anthracycline-based chemotherapy.

## Contribution

This is the first reported case of right atrial primary cardiac angiosarcoma presenting with cardiac rather than systemic symptoms.

## Key findings

- Diagnosis of cardiac angiosarcoma was confirmed via punch biopsy of a cutaneous lesion.
- Anthracycline-based chemotherapy showed clinical and radiologic response despite potential cardiotoxicity.

## Abstract

Angiosarcoma is a rare, aggressive malignancy originating from endothelial cells and associated with a poor prognosis. Diagnosis is histologically challenging. We present a rare case of cardiac angiosarcoma involving multiple presentations and investigations, which were inconclusive until a diagnosis was finally reached on a biopsy of a cutaneous lesion. Clinical and radiologic response to systemic anthracycline-based chemotherapy is discussed. This is the first reported case of right atrial primary cardiac angiosarcoma presenting with cardiac symptoms rather than systemic symptoms. The case illustrates the challenges associated with the diagnosis of this rare malignancy. It also highlights the feasibility of using anthracycline-based chemotherapy despite the potential cardiotoxicity of these agents.